The Independent |
 More than half of cancer drugs may not work, study suggests
The Independent A number of cancer drugs entered the European market “without evidence of benefit on survival or quality of life”, researchers have said. All new cancer drugs are given Europe-wide market approval through the European Medicines Agency (EMA). But a new ... Study Questions European Approval Process for Cancer Drugs No proof that most new cancer drugs extend life, study finds Over half of new cancer drugs 'show no benefits' for survival or wellbeing |
from Health - Google News http://ift.tt/2y1vXAe
EmoticonEmoticon